About Rumah Sakit Universitas Indonesia
Rumah Sakit Universitas Indonesia atau disingkat RS UI adalah rumah sakit universitas tipe B yang terletak area Universitas Indonesia. RS UI yang dibangun sejak tahun 2009 dan direncanakan beroperasi pada Oktober 2016 memiliki pelayanan unggulan di bidang Neurokardiovaskular, Geriatri dan Pelayanan Ibu dan Anak.
Clinical Trials at Rumah Sakit Universitas Indonesia
During the past decade, Rumah Sakit Universitas Indonesia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Rumah Sakit Universitas Indonesia"
#1 collaborator was "Fakultas Kedokteran Universitas Indonesia" with 1 trials as a collaborator, "Pusat Jantung Nasional Harapan Kita" with 1 trials as a collaborator, "RSUPN dr. Cipto Mangunkusumo" with 1 trials as a collaborator and "Rumah Sakit Universitas Indonesia" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Rumah Sakit Universitas Indonesia
According to Clinical.Site data, the most researched conditions in "Rumah Sakit Universitas Indonesia" are
"COVID-19" (1 trials), "Heart Diseases" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Rumah Sakit Universitas Indonesia" in a lesser frequency.
Clinical Trials Intervention Types at Rumah Sakit Universitas Indonesia
Most popular intervention types in "Rumah Sakit Universitas Indonesia" are "Biological" (1 trials), "Device" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Heart patch seeded with autologous cardiomyocytes and amnion epithelial stem cells" (1 trials), "Injection of secretome - mesenchymal stem cell" (1 trials), "Placebo" (1 trials) and "Standard treatment of Covid-19" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Rumah Sakit Universitas Indonesia
The vast majority of trials in "Rumah Sakit Universitas Indonesia" are
2 trials for "All" genders.
Clinical Trials Status at Rumah Sakit Universitas Indonesia
Currently, there are NaN active trials in "Rumah Sakit Universitas Indonesia".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Rumah Sakit Universitas Indonesia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Rumah Sakit Universitas Indonesia, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".